Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Aug;94(4):1149-56.
doi: 10.1111/j.1476-5381.1988.tb11633.x.

The actions of neuropeptide Y and peptide YY on the hepatic arterial and portal vascular beds of the anaesthetized dog

Affiliations

The actions of neuropeptide Y and peptide YY on the hepatic arterial and portal vascular beds of the anaesthetized dog

R Corder et al. Br J Pharmacol. 1988 Aug.

Abstract

1. The vascular actions of the two peptides, neuropeptide Y (NPY) and peptide YY (PYY) were compared with the transmitter noradrenaline (NA) on the arterial and portal vascular beds of the in situ liver of the anaesthetized dog. 2. The sole vascular response of the hepatic arterial vasculature to intra-arterial administration of either NPY or PYY was vasoconstriction; the duration of these responses was longer than that to NA. 3. The maximum hepatic arterial vasoconstrictor responses to PYY and to NPY were significantly different and they were both significantly less than the maximum to NA (P less than 0.001). 4. In contrast to its activity on the splenic arterial vasculature PYY was not more potent, on a molar basis, than NPY as an hepatic arterial vasoconstrictor agent. However, both peptides were significantly more potent than NA (P less than 0.005). 5. Neither peptide, when injected intraportally, caused any change in intrahepatic portal inflow resistance. 6. Both peptides when administered intraportally in doses which were free of systemic effects caused hepatic arterial vasoconstriction.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Regul Pept. 1986 Feb;13(3-4):307-18 - PubMed
    1. Eur J Pharmacol. 1986 Feb 11;121(1):25-30 - PubMed
    1. J Endocrinol. 1987 Apr;113(1):11-4 - PubMed
    1. Br J Pharmacol. 1987 Apr;90(4):785-90 - PubMed
    1. Int Rev Cytol. 1986;102:243-69 - PubMed

Publication types

LinkOut - more resources